Celgene Cellular Therapeutics
GPTKB entity
Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:focus |
gptkb:drug
|
| gptkbp:founded |
gptkb:2002
|
| gptkbp:founder |
gptkb:Celgene_Corporation
|
| gptkbp:headquarters |
gptkb:Summit,_New_Jersey
|
| https://www.w3.org/2000/01/rdf-schema#label |
Celgene Cellular Therapeutics
|
| gptkbp:key_people |
gptkb:Dr._John_D._Mc_Carty
gptkb:Dr._David_Chang gptkb:Dr._Richard_A._Miller gptkb:Dr._John_D._Mc_Carthy Dr. Robert A. Lutz Dr. Michael Pehl Dr. Robert Nussbaum Dr. David H. Hyman Dr. Michael J. Haller Dr. Steven A. Rosenberg |
| gptkbp:part_of |
gptkb:Celgene_Corporation
|
| gptkbp:products |
CART-cell therapies
|
| gptkbp:research_areas |
oncology
autoimmune diseases |
| gptkbp:type |
gptkb:Company
|
| gptkbp:website |
www.celgene.com
|
| gptkbp:bfsParent |
gptkb:Celgene_Corporation
|
| gptkbp:bfsLayer |
3
|